Get started
Author

Anastasiia O. Sosnovtseva

Observed names: A O Sosnovtseva, A. O. Sosnovtseva, A. Sosnovtseva, A.O. Sosnovtseva, Anastasia O. Sosnovtseva, Anastasia Olegovna Sosnovtseva, А. О. Сосновцева, А.О. Сосновцева
Observed institutions: Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation, Federal Medical Research Centre for Psychiatry and Narcology, Vavilov Institute of General Genetics
ORCID: 0000-0002-1586-5264
Observed ORCID: 0000-0002-1586-5264
OpenAlex ID: A5047626329
Systemic and local immunosuppression in glioblastoma and its prognostic significance
2024 · Aleksei A. Stepanenko, Anastasiia O. Sosnovtseva, et al. · Frontiers in Immunology · 50
PDF
Epigenome Engineering Using dCas Systems for Biomedical Applications and Biotechnology: Current Achievements, Opportunities and Challenges
2025 · Maxim A. Kovalev, Naida Yu. Mamaeva, et al. · International Journal of Molecular Sciences · 30
PDF
Challenges of CRISPR/Cas-Based Cell Therapy for Type 1 Diabetes: How Not to Engineer a “Trojan Horse”
2023 · Dmitry S. Karpov, Anastasiia O. Sosnovtseva, et al. · International Journal of Molecular Sciences · 30
PDF
Superior infectivity of the fiber chimeric oncolytic adenoviruses Ad5/35 and Ad5/3 over Ad5-delta-24-RGD in primary glioma cultures
2021 · Aleksei A. Stepanenko, Anastasiia O. Sosnovtseva, et al. · Molecular Therapy — Oncolytics · 30
PDF
The need for paradigm shift: prognostic significance and implications of standard therapy-related systemic immunosuppression in glioblastoma for immunotherapy and oncolytic virotherapy
2024 · Aleksei A. Stepanenko, Anastasiia O. Sosnovtseva, et al. · Frontiers in Immunology · 23
PDF
A new insight into aggregation of oncolytic adenovirus Ad5-delta-24-RGD during CsCl gradient ultracentrifugation
2021 · Aleksei A. Stepanenko, Anastasiia O. Sosnovtseva, et al. · Scientific Reports · 23
PDF
Aberrant Splicing of INS Impairs Beta-Cell Differentiation and Proliferation by ER Stress in the Isogenic iPSC Model of Neonatal Diabetes
2022 · Alexandra V. Panova, Natalia V. Klementieva, et al. · International Journal of Molecular Sciences · 20
PDF
In Vivo Tracking for Oncolytic Adenovirus Interactions with Liver Cells
2022 · Victor A. Naumenko, Daniil A. Vishnevskiy, et al. · Biomedicines · 17
PDF
Recombinant Adenoviruses for Delivery of Therapeutics Following Spinal Cord Injury
2022 · Anastasiia O. Sosnovtseva, Olga V. Stepanova, et al. · Frontiers in Pharmacology · 9
PDF
Study of the Therapeutic Efficiency of Transduced Olfactory Ensheathing Cells in Spinal Cord Cysts
2021 · Olga V. Stepanova, Anastasia D. Voronova, et al. · Stem Cells and Development · 8
Sensitivity of C6 Glioma Cells Carrying the Human Poliovirus Receptor to Oncolytic Polioviruses
2016 · A. O. Sosnovtseva, A. V. Lipatova, et al. · Bulletin of Experimental Biology and Medicine · 8
Relationship between Cell Receptors and Tumor Cell Sensitivity to Oncolytic Enteroviruses
2018 · A. V. Lipatova, T. H. Le, et al. · Bulletin of Experimental Biology and Medicine · 7
Control of HSV-1 Infection: Directions for the Development of CRISPR/Cas-Based Therapeutics and Diagnostics
2024 · Anastasiia O. Sosnovtseva, Natalia A. Demidova, et al. · International Journal of Molecular Sciences · 6
Biomarkers of prostate cancer sensitivity to the Sendai virus
2017 · A. A. Belova, A. O. Sosnovtseva, et al. · Molecular Biology · 6
Application of a New Gene-Cell Construct Based on the Olfactory Mucosa Escheating Cells Transduced with an Adenoviral Vector Encoding Mature BDNF in the Therapy of Spinal Cord Cysts
2022 · E. K. Karsuntseva, G. A. Fursa, et al. · Bulletin of Experimental Biology and Medicine · 4
Human enteroviruses exhibit selective oncolytic activity in the model of human glioblastoma multiforme xenografts in immunodeficient mice
2018 · A.O. Zheltukhin, A.V. Soboleva, et al. · Bulletin of Russian State Medical University · 4
Comparison of the L3-23K and L5-Fiber Regions for Arming the Oncolytic Adenovirus Ad5-Delta-24-RGD with Reporter and Therapeutic Transgenes
2025 · Aleksei A. Stepanenko, Anastasiia O. Sosnovtseva, et al. · International Journal of Molecular Sciences · 3
PDF
Obtaining a New Gene-Cell Construct Based on Transduced Olfactory Ensheathing Cells for the Treatment of Spinal Cord Injuries
2022 · A. D. Voronova, A. O. Sosnovtseva, et al. · Bulletin of Experimental Biology and Medicine · 3
Oncolytic Activity of the Vaccine Strain of Type 3 Poliovirus on the Model of Rat Glioma C6 Cells
2019 · A. O. Sosnovtseva, A. O. Zheltukhin, et al. · Bulletin of Experimental Biology and Medicine · 3
Establishment of a Panel of Human Cell Lines to Identify Cellular Receptors Used by Enteroviruses to Infect Cells
2025 · Anastasiia O. Sosnovtseva, Le T. Hoa, et al. · International Journal of Molecular Sciences · 2
PDF
Энтеровирусы человека проявляют избирательную онколитическую активность на модели ксенотрансплантатов мультиформной глиобластомы человека в иммунодефицитных мышах
2018 · Институт молекулярной биологии имени В. А. Энгельгардта, Москва, А.О. Желтухин, et al. · Вестник Российского государственного медицинского университета · 2
PDF
Humanized Murine Glioblastoma Models for Evaluation of Coxsackievirus Oncolytic Therapy
2026 · Yana D. Gumennaya, Marat P. Valikhov, et al. · Cancers · 1
PDF
Immune Evasion Strategies of Human Poxviruses: A Roadmap for Engineering Low-Immunogenic CAR-Based and iPSC-Derived Cell Products
2026 · Daniil O. Antonov, Marina Yu. Loguinova, et al. · Cells
Potency-enhancing mutations in E3-19K and i-leader increase the cytolytic activity of the PH20/SPAM1-armed oncolytic adenovirus Ad5Δ24RGD
2026 · Aleksei A. Stepanenko, Anastasiia O. Sosnovtseva, et al. · Molecular Therapy Oncology
DNA Double-Strand Break Repair System by a Mechanism of Non-Homologous End Joining Provides Resistance to DNA-Damaging and Oxidizing Stresses in the Yeast Debaryomyces hansenii
2025 · A. I. Cherdantsev, K. A. Kulagin, et al. · Molecular Biology
Works count: 33
Citation count: 289
H-index: 9
I10-index: 8
Year
Topic
Type